AstraZeneca On Tagrisso's Milestone Advance Into Adjuvant Lung Cancer

 
• By Jessica Merrill
  
Astrazeneca
AstraZeneca's Tagrisso is approved in adjuvant NSCLC • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Anticancer

More from Therapy Areas